Target Price | $7.14 |
Price | $1.12 |
Potential |
537.50%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Aileron Therapeutics, Inc. 2026 .
The average Aileron Therapeutics, Inc. target price is $7.14.
This is
537.50%
register free of charge
$7.35
556.25%
register free of charge
$7.07
531.25%
register free of charge
|
|
A rating was issued by 6 analysts: 0 Analysts recommend Aileron Therapeutics, Inc. to buy, 3 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aileron Therapeutics, Inc. stock has an average upside potential 2026 of
537.50%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.51 | -0.94 |
2.63% | 73.22% | |
P/E | negative |
3 Analysts have issued a Aileron Therapeutics, Inc. forecast for earnings per share. The average Aileron Therapeutics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Aileron Therapeutics, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Brookline Capital |
Locked
➜
Locked
|
Locked | Aug 19 2025 |
Analyst Rating | Date |
---|---|
Locked
Brookline Capital:
Locked
➜
Locked
|
Aug 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.